Jun 10, 2026Confidence A
Product0 evidence links
Silmaril product scope reviewed
Silmaril public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Prompt injection defense that is self-healing
Silmaril public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Silmaril public source reviewed for capital or strategic-status timeline signal.
No source evidence matched to this event.Silmaril official source reviewed for product scope, operating focus, and category placement.
Open sourceSilmaril public capital or strategic-status source reviewed for stage and timeline signal.
Open source